FREDERICK, MD–(Marketwired – Nov 13, 2017) – BioElectronics Corporation (OTC PINK: BIEL) is the maker of advanced, non-prescription pain management medical devices. We are pleased to announce that PharmEvo, our distributor in Vietnam, is hosting an Electroceuticals symposium following a successful launch of their sales & marketing strategy. Additionally, PharmEvo is expanding their territory to cover … Continue Reading
Author Archives
ianwar@bielcorp.com
BioElectronics to Showcase Products at World’s Largest Medical Tradeshow
FREDERICK, MD–(Marketwired – Nov 9, 2017) – BioElectronics Corporation (OTC PINK: BIEL) is the maker of advanced, non-prescription pain management medical devices. The company announced today that it will showcase its range of pain and inflammation reduction products at MEDICA 2017 in Germany, dubbed as the leading international tradeshow for the medical industry. The company will … Continue Reading
BioElectronics Announces Drug Free Solution to the Opioid Crisis (ActiPatch)
FREDERICK, MD–(Marketwired – Nov 6, 2017) – BioElectronics Corporation ( OTC PINK :BIEL ), the maker of advanced consumer pain management medical device, ActiPatch, today announced that it has taken on the responsibility to find a DRUG-FREE solution to the Opioid Crisis. The reach of the opioid crisis now stretches wide and far, claiming an American life every … Continue Reading
BioElectronics Announces Independent Back Pain Clinical Study Pulsed Neuromodulation Therapy (ActiPatch) for Chronic Musculoskeletal Lower Back Pain
FREDERICK, MD–(Marketwired – Oct 16, 2017) – BioElectronics Corporation ( OTC PINK : BIEL ), www.bielcorp.com is pleased to announce the commencement of a clinical study investigating the efficacy of ActiPatch in treating chronic musculoskeletal lower back pain. Low back pain is highly prevalent and affects 1 in 3 adult Americans, accounting for about $ 90 billion in direct spending every … Continue Reading
BioElectronics Completes Subject Enrollment for Migraine Clinical Study; Migraine Prevention Using ActiPatch (Neuromodulation Therapy)
FREDERICK, MD–(Marketwired – Sep 25, 2017) – BioElectronics Corporation ( OTC PINK : BIEL ), www.bielcorp.com is pleased to report on the progress of its Migraine prevention clinical study. The randomized, double-blinded, sham-controlled study involving 48 subjects is designed to investigate if ActiPatch therapy can be used to prevent the frequency and intensity of migraine attacks. Since receiving IRB-approval for the … Continue Reading
Letter from BioElectronics’ (OTC PINK: BIEL) President to Investors
FREDERICK, MD–(Marketwired – Aug 28, 2017) – The following is a statement from BioElectronics ( OTC PINK : BIEL ). Dear Fellow Shareholders, These are busy and exciting times at BioElectronics ( OTC PINK : BIEL ). New Product Opportunities Over the last few years, there have been two significant developments: 1) There has been a paradigm shift in the medical community’s understanding of how … Continue Reading
BioElectronics’ President Discusses Company’s Many Opportunities
FREDERICK, MD–(Marketwired – Aug 22, 2017) – The following is a statement from BioElectronics ( OTC PINK : BIEL ). Dear Fellow Shareholders, These are busy and exciting times at BioElectronics. New Product Opportunities Over the last few years, there have been two significant developments: 1) There has been a paradigm shift in the medical community’s understanding of how … Continue Reading
BioElectronics Engages Keith Nalepka As Vice President of Sales and Marketing
FREDERICK, MD–(Marketwired – Aug 22, 2017) – BioElectronics Corporation ( OTC PINK : BIEL ), the maker of advanced consumer pain management medical devices, today announced that it has engaged Keith Nalepka as the Vice President of Sales and Marketing. Keith has over 15 years of experience working in the retail sales industry, both with large multi-million dollar brands … Continue Reading
BioElectronics Announces Update on Migraine Clinical Study Migraine Prevention Using ActiPatch (Neuromodulation Therapy)
FREDERICK, MD–(Marketwired – Aug 8, 2017) – BioElectronics Corporation ( OTC PINK :BIEL ), www.bielcorp.com is pleased to report on the progress of its Migraine prevention clinical study. The randomized, double-blinded, sham-controlled study involving 48 subjects is designed to investigate if ActiPatch therapy can be used to prevent the frequency and intensity of migraine attacks. Since receiving IRB-approval for the … Continue Reading
BioElectronics Wins the Orthopedics This Week 2017 Sports Medicine Technology Award
FREDERICK, MD–(Marketwired – Aug 2, 2017) – ( OTC PINK : BIEL ) BioElectronics Corporation’s ActiPatch®, The New Technology for Pain Relief medical device, has won the Orthopedics This Week Sports Medicine Technology Award. Orthopedics This Week is the most widely read publication by clinicians, nurses, scientists, and others in the orthopedics industry. The panel of judges consisted of experienced orthopedic sports medicine … Continue Reading